BBP

BioShares Biotechnology Products ETF

Up$36.18
+$0.66
(+1.86%)
As of 4:10:00 PM EDT | 10/15/19  |  Market Closed

BBP Trading Data

Open

$36.02

Low Price

$36.02

High Price

$36.25

Previous Last Price

$35.52

Bid Size

$0 X 0

Ask Size

$0 X 0

BBP Portfolio Data

AUM

$24,654,000

Shares

700

PE Ratio

0

Price / Book Ratio

4.75

Expense Ratio

0.79

Net Asset Value

$35.22

Volume

Volume

1,913

Avg. Volume (YDT)

4,496

Dollar Volume

$66,862

Weekly Avg. Volume

1,603

Monthly Avg. Volume

2,106

Quarterly Avg. Volume

3,720

BBP Fund Description

The BioShares Biotechnology Products Fund seeks investment results that correspond to the performance of the BioShares Biotechnology Products Index. Products stage companies are typically more established companies with much clinical trial failure risk behind them.

BBP Chart

BBP Summary

Fund Family

BioShares

Tracks This Index

BioShares Biotechnology Products ETF

Inception Date

2014-12-17

Asset Class

Portfolio-Multi Asset

Asset Class Size

Biotech

BBP Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

BBP Holdings

Top 10 Holdings

ACADIA Pharmaceuticals Inc (ACAD)
4.69%
Medicines Co/The (MDCO)
4.17%
Seattle Genetics Inc (SGEN)
3.35%
Amgen Inc (AMGN)
3.17%
Theravance Biopharma Inc (TBPH)
3.14%
Alnylam Pharmaceuticals Inc (ALNY)
3.11%
Radius Health Inc (RDUS)
3.11%
Momenta Pharmaceuticals Inc (MNTA)
3.07%
Neurocrine Biosciences Inc (NBIX)
2.96%
Celgene Corp (CELG)
2.9%

Total BBP Holdings

Total Holdings: 42

ACADIA Pharmaceuticals Inc (ACAD)
4.69%
Medicines Co/The (MDCO)
4.17%
Seattle Genetics Inc (SGEN)
3.35%
Amgen Inc (AMGN)
3.17%
Theravance Biopharma Inc (TBPH)
3.14%
Alnylam Pharmaceuticals Inc (ALNY)
3.11%
Radius Health Inc (RDUS)
3.11%
Momenta Pharmaceuticals Inc (MNTA)
3.07%
Neurocrine Biosciences Inc (NBIX)
2.96%
Celgene Corp (CELG)
2.9%
United Therapeutics Corp (UTHR)
2.9%
Portola Pharmaceuticals Inc (PTLA)
2.87%
Ionis Pharmaceuticals Inc (IONS)
2.81%
Vertex Pharmaceuticals Inc (VRTX)
2.81%
Halozyme Therapeutics Inc (HALO)
2.79%
Biogen Inc (BIIB)
2.76%
Regeneron Pharmaceuticals Inc (REGN)
2.75%
Incyte Corp (INCY)
2.74%
Ligand Pharmaceuticals Inc (LGND)
2.69%
Gilead Sciences Inc (GILD)
2.68%
Omeros Corp (OMER)
2.62%
Vanda Pharmaceuticals Inc (VNDA)
2.42%
Exelixis Inc (EXEL)
2.36%
Alexion Pharmaceuticals Inc (ALXN)
2.35%
Ironwood Pharmaceuticals Inc (IRWD)
2.32%
BioMarin Pharmaceutical Inc (BMRN)
2.31%
Sage Therapeutics Inc (SAGE)
2.2%
Intercept Pharmaceuticals Inc (ICPT)
2.08%
Ultragenyx Pharmaceutical Inc (RARE)
2.05%
Sarepta Therapeutics Inc (SRPT)
1.95%
Enanta Pharmaceuticals Inc (ENTA)
1.91%
Amicus Therapeutics Inc (FOLD)
1.89%
Agios Pharmaceuticals Inc (AGIO)
1.86%
Stemline Therapeutics Inc (STML)
1.71%
Lexicon Pharmaceuticals Inc (LXRX)
1.68%
Retrophin Inc (RTRX)
1.62%
BNY MELLON CASH RESERVE USD
1.62%
Puma Biotechnology Inc (PBYI)
1.59%
Nektar Therapeutics (NKTR)
1.36%
Clovis Oncology Inc (CLVS)
0.69%
Virtus LifeSci Biotech Products ETF (BBP)
0%
Cash/Cash equivalents
0%

BBP Technicals

Alpha

-4.4

Beta

1.55

Leverage

Long

Standard Deviation

2.95

BBP Dividends

Dividend Date

2017-12-20

Latest Dividend

0.072

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

BBP Performance

YTD Return

3.68%

1 Year Return

-10.32%

3 Year Return

17.01%

5 Year Return

0%

10 Year Return

36%

BBP Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.